Drug choice and therapeutic drug monitoring in the management of canine primary epilepsy : continuing education

Journal of the South African Veterinary Association

 
 
Field Value
 
Title Drug choice and therapeutic drug monitoring in the management of canine primary epilepsy : continuing education
 
Creator Vaughan, T. Taylor, J.H.
 
Subject — Canine; Drug Choice; Epilepsy; Therapeutic Drug Monitoring; Treatment
Description Therapeutic drug monitoring is an underutilised resource in the management of canine primary epilepsy. Many of the anti-epileptic drugs, including phenobarbitone, have variable pharmacokinetic profiles in different dogs, with each individual animal showing variable rates of absorption, distribution, metabolism and excretion. This results in variable serumdrug concentrations with the same oral dose. Many clinicians interpret this situation as therapeutic failure and classify these patients as refractory to treatment. By measuring blood concentrations of drugs at appropriate times, it is possible to explain the efficacy or failure of treatment, and also to prevent serum concentrations from reaching toxic levels. By analysing paired samples, key pharmacokinetic parameters may be calculated for each patient and a profile for the disposition of the drug obtained. Individual optimal drug dosage can be calculated for each patient at little cost to the pet owner.
 
Publisher AOSIS
 
Contributor
Date 1999-07-12
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format application/pdf
Identifier 10.4102/jsava.v70i4.791
 
Source Journal of the South African Veterinary Association; Vol 70, No 4 (1999); 172-176 2224-9435 1019-9128
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://jsava.co.za/index.php/jsava/article/view/791/764
 
Coverage — — —
Rights Copyright (c) 1999 T. Vaughan, J.H. Taylor https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT